Articles On Elixinol Global (ASX:EXL)

“To exceed our SPP target is a very strong signal that our shareholders have the confidence in our business outlook," says CEO

The company is submitting a Novel Foods application in Europe, expanding its CBD product range across the US given an increasingly favourable regulatory outlook and continuing the growth of its market-leading Hemp Foods Australia brand.

The Elixinol Global Ltd (ASX: EXL) share price tumbled after management issued an update to its share purchase plan (SPP) today. The EXL share price lost 7.6% to 24 cents in after lunch trade when the S&P/ASX 200 Index (Index:^AXJO) ga...

The company has received applications in excess of A$1.3 million of the A$2 million SPP target.

The Elixinol Global Ltd (ASX: EXL) share price soared today, after it was announced that the United Nations (UN) has rescheduled its classification of cannabis. According to the company, this is expected to favourably impact its global bus...

This UN decision, which acknowledges medicinal usefulness of cannabis and clarifies that CBD is not under international drug control, is expected to have a substantial impact on Elixinol’s ability to drive product sales in Europe and other...

CBD hemp oil products maker Elixinol Global landed in front of small cap fund managers on Friday morning, seeking an equity injection.

The Elixinol Global Ltd (ASX: EXL) share price is on fire today, up more than 55% at the time of writing to 22 cents a share. The Elixinol share price closed at 14 cents a share last week, but opened this morning at 16 cents a share and ha...

After a ripper period in early 2019, the Elixinol Global Ltd [ASX:EXL] share price went on a long-term slide. On a day where the EXL share price was up 3.33% to trade at 15.5 cents, we take a look at the numbers from EXL quarterly update......

ASX cannabis stocks are continuing their victory lap following yesterday’s decision by the TGA to re-classify low-dose cannabidiol (CBD) products. The TGA has made an interim decision to down schedule CBD products, including oil and pills,...

Elixinol (ASX: EXL) will finally be able to sell its CBD products in Australia after penning an exclusive distribution agreement with licenced wholesaler PharmaCann. Under the agreement PharmaCann will import and supply Elixinol's branded...

With less than a month to go of the 2019-20 financial year, time is running out for share market investors to minimise their tax bill. One way is by selling stocks investors have made a loss on and claiming them as an offset against any cap...

For the many companies in Australia’s medicinal cannabis sector, the health benefits of cannabidiol (CBD) products are self-evident. But a trial underway in the UK is also testing the safety and efficiency of cannabis-derived medicines to t...

An IPO (or Initial Public Offering) can be an exciting event on the ASX, or any other share market for that matter. That’s because it involves the process of a private company becoming public, with its shares trading on the stock exchange...

Queensland medical marijuana group THC Global (ASX:THC) has started selling its products in Australia, with the first one available by prescription under the government’s Special Access Scheme (SAS). THC is one of several companies which an...

A quick wrap of the key winners and losers on Thursday, May 14. Data is taken after the market closes at 4pm EST. Stocks highlighted in yellow made market-moving announcements during the day. Code Company Price % Change Volume...

Stockhead’s Top 10 at 10 highlights the best (and worst) performing ASX small caps in morning trade. It’s a short, sharp update to help frame the trading day by showing the biggest movers in percentage terms. The market opens at 10am (easte...

A quick wrap of the key winners and losers on Tuesday, May 12. Data is taken after the market closes at 4pm EST. Stocks highlighted in yellow made market-moving announcements during the day. Code Company Price % Change Volume...

A fair chunk of ASX-listed companies have had little difficulty in raising capital recently, but the good run won’t last forever. In April, small caps with market capitalisations between $100m and $500m raised $583m while micro-caps worth l...

Stockhead’s Top 10 at 10 highlights the best (and worst) performing ASX small caps in morning trade. It’s a short, sharp update to help frame the trading day by showing the biggest movers in percentage terms. The market opens at 10am (easte...

A quick wrap of the key winners and losers on Monday, May 11. Data is taken after the market closes at 4pm EST. Stocks highlighted in yellow made potentially market-moving announcements during the day.   WINNERS CODE NAME PRICE...

In afternoon trade the S&P/ASX 200 Index (ASX: XJO) is off its low but remains on course to end its winning streak. The benchmark index is down 0.75% to 5,367.3 points at the time of writing. Four shares falling more than most today ar...

The Australian drugs regulator is weighing whether to allow cannabidiol-only (CBD) products to be sold over the counter in pharmacies, bringing it into line with other countries where medical marijuana is legal. The Therapeutic Drug Adminis...

The former CEO of Swisse Wellness Oliver Horn (pictured) has been appointed as the CEO of Australia's leading cannabis company Elixinol (ASX: EXL). Horn's experience with the vitamin giant will serve him well at Elixinol a cannabis stock...

Nine months after he resigned as CEO and three months after quitting as chief innovation officer, Elixinol (ASX:EXL) founder Paul Benhaim is back as chairman. He replaces Andrew Duff, who chaired the company from its 2018 ASX listing, and G...

An additional news report on the recommendation, valuation, forecast and opinion changes for ASX-listed equities. In addition to The Australian Broker Call Report, which is published and updated daily (Mon-Fri), FNArena has now added The Au...

Stockhead’s Top 10 at 10 highlights the best (and worst) performing ASX small caps in morning trade. It’s a short, sharp update to help frame the trading day by showing the biggest movers in percentage terms. The market opens at 10am (easte...

The Elixinol Global Ltd (ASX: EXL) share price is pushing higher on Thursday despite it announcing an $83.5 million full year loss. In afternoon trade the cannabis company’s shares are up 3.5% to 44.5 cents. They were up 9% at one stage to...

Two years ago Zelira (ASX:ZLD) — then Zelda — was set to invade the German market, planning to storm the walls with unregistered marijuana products that had a little bit of clinical data behind them, data which would be the reason for a big...

The breakdown in the corporate North American marijuana sector is having ramifications in the Australian industry, and it’s unclear how big an impact the ructions will continue to have. Lower than expected take up of recreational marijuana...

Just a day after Elixinol's (ASX: EXL) fire sale of Hemp Foods Australia (HFA), another hemp company has reported an encouraging result to the market. Ecofibre (ASX: EOF), one of Australia's largest growers of hemp foods and a seller of h...

Elixinol Global (ASX:EXL) is bleeding money and is holding a fire sale of its global hemp and medical cannabis assets. Today the company said it was selling its Hemp Foods Australia subsidiary to a Chinese buyer for just $500,000. It is kil...

The Elixinol Global Ltd (ASX: EXL) share price was a very poor performer on Friday. The cannabis company’s shares finished the week with a massive 14% decline to 77 cents. Its shareholders will no doubt be hoping for better on Monday. Thou...

ASX cannabis shares endured a tough 2019, as investors cooled on the latest investing trend. However, some of the biggest listed groups have bounced back in January and are up as much as 100% this year. Here’s why 3 of the biggest names in...

The survival of the southern Western Australia town of Collie is inextricably linked to the fortunes of the coal mines it was built on. But with the dire situation in coal escalating for the tiny town, cannabis could be its saving grace. Co...

For an industry that’s projected to reach $US20 billion ($29 billion) by 2024 in the US, the cannabidiol (CBD) market there is very much the wild west. A study from researcher Leafreport comparing 3500 products for the sale in the US from 5...

Marijuana is the hottest herb on the planet right now, but while investing in medical cannabis stocks could make you a fortune, it could also risk the house. After a flurry of activity on the ASX in 2017 as the sector kicked off following l...

When Canberra became the first Australian jurisdiction to legalise cannabis in September it was the bud for many companies to stem out into a fast growing industry. Throughout the latter half of 2019, many CBD-focused companies took adv...

There is a lot of optimism surrounding the outlook for the multi-billion-dollar global cannabis industry, which may not be still evident from the share prices but increasing number of nations are now introducing proper legal framework to ba...

An Initial Public Offering (IPO) is a process in which a private company offers its shares to the public through stock issuance. An IPO is the best way for a company to raise a substantial amount of capital to expand its operations. The fun...

The Elixinol Global Ltd (ASX: EXL) share price looks set to end the week on a very disappointing note. The cannabis company’s shares are down over 9% to a 52-week low of 58 cents this afternoon. This means Elixinol Global’s shares have fal...

Canadians rolled some big… notes last year after handing over $C1 billion ($1.5 billion) or $C24 a person for legal cannabis. Ontario topped the lot, shelling out $C217m on recreational cannabis in the year to September 2019. Regulators in...

Escrow Watch is Stockhead’s fortnightly recap of the small cap companies releasing shares that have been locked away in escrow. Escrow refers to shares that are held by early investors or directors restrained from selling for a year or two....

The cannabis sector globally is defined in part by its multi-speed regulatory backdrop. For example, THC products are legalised at the federal level in Canada, but not the US (or Australia). US lawmakers did pass the Farm bill last December...

Although the share market has been flying high this year, not all shares have been able to follow its lead. Three ASX shares that have just hit multi-year lows or worse are listed below. Here’s why they are down in the dumps right now: Ba...

In afternoon trade the S&P/ASX 200 index is on course to start the week on a positive note. At the time of writing the benchmark index is up 0.35% to 6,731.1 points. Four shares that have failed to follow the market higher today are li...

The Elixinol Global Ltd (ASX: EXL) share price is among the biggest losers on the market today after the stock crashed on a dimming outlook and a broker downgrade. The EXL share price tumbled 18% during lunch time trade to a record low of...

Stockhead’s Top 10 at 10 highlights the best (and worst) performing ASX small caps in morning trade. It’s a short, sharp update to help frame the trading day by showing the biggest movers in percentage terms. The market opens at 10am (easte...